Report: J&J nearing hip settlement

Share this article:

Johnson & Johnson may be nearing a settlement over hip replacements manufactured by its DePuy subsidiary. The New York Times reports that the company may agree to pay out close to $4 billion over the Articular Surface Replacement hips which shed metal fragments in patients as the devices wore down.

The New York Times says the number has to be approved by the court and the total could change, since the number of eligible patients has to be determined. The current estimate is that a settlement could affect 7,000 to 8,000 patients.

The company has been taking an increasing amount of heat over the faulty hip replacements: as noted by the Times the hips were not just faulty, but company documents show the subsidiary knew there were problems with the design.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.